Literature DB >> 32713251

COVID-19: A Perspective from Clinical Neurology and Neuroscience.

Adriana Pero1, Sabrina Ng2, Dongming Cai1.   

Abstract

Despite the increasing large population of COVID-19+ infected patients, knowledge of the disease remains limited. Understanding the effects and long-term implications of COVID-19 will be paramount to implementing the right public health measures and developing future preventive and effective treatments. In this article, we discuss currently available information with COVID-19-related neurological complications, possible routes of virus infection into the central nervous system, and hypothesis about virus-induced cytokine storm syndrome, long-term outcomes, as well as ongoing clinical studies of novel therapies and biomarkers for COVID-19. Understanding the effects of COVID-19 on neurological systems is crucial for properly diagnosing and caring for the disease. We need to be prepared that COVID-19 could cause long-lasting debilitations after the infection has cleared. Investigating long-term effects of the disease will yield insight for providing comprehensive care to the survivors. Understanding these risks will also lead to better treatments as well as inform policies to create a system capable of caring for those affected by COVID-19 long after the pandemic has subsided.

Entities:  

Keywords:  COVID-19; biomarkers; long-term effects; neurological symptoms; novel therapies

Mesh:

Substances:

Year:  2020        PMID: 32713251     DOI: 10.1177/1073858420946749

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  7 in total

1.  Describing cognitive function and psychosocial outcomes of COVID-19 survivors: A cross-sectional analysis.

Authors:  Ashley M Henneghan; Kimberly A Lewis; Eliana Gill; Oscar Y Franco-Rocha; Ruben D Vela; Sarah Medick; Shelli R Kesler
Journal:  J Am Assoc Nurse Pract       Date:  2021-08-27       Impact factor: 1.165

Review 2.  Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.

Authors: 
Journal:  Lancet       Date:  2020-09-14       Impact factor: 79.321

3.  Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID.

Authors:  Erin Clough; Joseph Inigo; Dhyan Chandra; Lee Chaves; Jessica L Reynolds; Ravikumar Aalinkeel; Stanley A Schwartz; Alexander Khmaladze; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-02       Impact factor: 7.285

4.  Retrospective and prospective monitoring in post COVID-19 complications and an approach for vigilance in Post-recovery period.

Authors:  Devulapalli S Rao; Yousra A Nomier; Rayan A Ahmed; Amal N Noureldeen
Journal:  J Adv Pharm Technol Res       Date:  2021-04-27

5.  Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

Authors:  Marc Scherlinger; Renaud Felten; Floriane Gallais; Charlotte Nazon; Emmanuel Chatelus; Luc Pijnenburg; Amaury Mengin; Adrien Gras; Pierre Vidailhet; Rachel Arnould-Michel; Sabrina Bibi-Triki; Raphaël Carapito; Sophie Trouillet-Assant; Magali Perret; Alexandre Belot; Seiamak Bahram; Laurent Arnaud; Jacques-Eric Gottenberg; Samira Fafi-Kremer; Jean Sibilia
Journal:  Infect Dis Ther       Date:  2021-07-10

6.  COVID-19 outbreak, herd immunity formation, and future public health strategies.

Authors:  Youngtaek Kim; Yoon Hyung Park
Journal:  Epidemiol Health       Date:  2021-09-16

Review 7.  COVID-19 and micronutrient deficiency symptoms - is there some overlap?

Authors:  Sherri L Lewis; Lora R Chizmar; Sydni Liotta
Journal:  Clin Nutr ESPEN       Date:  2022-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.